Skip to content
+1-516-222-6222
LCS@lachmanconsultants.com
Search
Location Selector

Current Location

  • - Global Website

  • - Ireland Website
  • About
    • Lachman Leadership Team
    • Lachman Board of Directors
  • Services
    • FDA-Related Services
    • Compliance
    • Regulatory Affairs
    • FDA 483 Response
    • Data Integrity
    • Mock FDA Inspections
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Remote Services From Lachman
  • Markets
    • Biologics
    • Advanced Therapies
    • Pharmaceuticals
    • Medical Devices
    • Related Industries
  • Blog
  • News
  • Contact
  • Careers
    • Career Opportunities
  • Resources
    • Lachman Learning
  • Location Selector
    • – Global Website
    • – Ireland Website

AGDUFAs

Lachman Consultant Services, Inc. / Blog / AGDUFAs
30
Jul
fees

The UFA’s FY 2021 Fee Adjustments Are Off and Running

By Bob Pollock    Jul 30, 2020    ADUFA AGDUFAs FDA MDUFA PDUFA Regulatory Affairs User Fees

Today, the announcement of the User Fees for three FDA programs today were published in the Federal Register notice prepublication.  PDUFA, animal and generic drug fees and medical device fees for FY 2021 start October 1, 2020 and are provided below.  We await the GDUFA fee announcement, which we should see in a day or […]

Read More

Subscribe to our blog

Recent Articles

  • January 14, 2026 GDUFA Negotiation Session
  • FDA Approved Modifications to iPLEDGE REMS Program for Isotretinoin Products
  • Lachman Consultants at the 11th Global Pharmaceutical Quality Summit

Contact Us:



Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA and industry experts has offered compliance, regulatory affairs, and technical services to clients around the world.
+1-516-222-6222
LCS@lachmanconsultants.com

 

Subscribe to our blog

Quick Links

  • Home
  • About
  • Services
  • Areas Served
  • Markets
  • Careers
  • Blog
  • Contact

Recent Posts

  • January 14 2026 GDUFA Negotiation Session - Lachman BlogJanuary 14, 2026 GDUFA Negotiation Session
    February 12, 2026
  • iPledge-Blogimage-LachmanBlogFDA Approved Modifications to iPLEDGE REMS Program…
    February 11, 2026
  • Poker Showdown Full HouseCompounding Showdown Set to Go to Court
    February 10, 2026
2026 © Lachman Consultant Services, Inc.Terms and ConditionsPrivacy Policy
  • About
    ▼
    • Lachman Leadership Team
    • Lachman Board of Directors
  • Services
    ▼
    • FDA-Related Services
    • Compliance
    • Regulatory Affairs
    • FDA 483 Response
    • Data Integrity
    • Mock FDA Inspections
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Remote Services From Lachman
  • Markets
    ▼
    • Biologics
    • Advanced Therapies
    • Pharmaceuticals
    • Medical Devices
    • Related Industries
  • Blog
  • News
  • Contact
  • Careers
    ▼
    • Career Opportunities
  • Resources
    ▼
    • Lachman Learning
  • Location Selector
    ▼
    • – Global Website
    • – Ireland Website
Manage Consent

We use cookies and similar technologies to improve site performance, personalize content, analyze traffic, and for marketing purposes. You can accept all cookies, reject non-essential cookies, or manage your preferences. You may change or withdraw your consent at any time in our Cookie Settings.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}